Ananth Sridhar

Title: Ananth Sridhar: Innovator in Calcilytic Compounds

Introduction

Ananth Sridhar is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for treating autosomal dominant hypocalcemia (ADH). His innovative work has the potential to impact many lives.

Latest Patents

Ananth holds a patent for "Formulations of triphenyl calcilytic compounds." This patent provides tablet formulations that include a triphenyl calcilytic compound for the treatment of ADH. The compound is represented by a specific formula and includes various forms such as solvates, hydrates, and pharmaceutically acceptable salts.

Career Highlights

Ananth Sridhar has established himself as a key figure in the pharmaceutical industry. He is currently associated with Calcilytix Therapeutics, Inc., where he continues to innovate and develop new therapeutic solutions. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Ananth collaborates with talented professionals in his field, including Uma Sinha and Leena Prasad. These partnerships enhance the research and development efforts at Calcilytix Therapeutics, Inc., fostering an environment of innovation and creativity.

Conclusion

Ananth Sridhar is a dedicated inventor whose work in calcilytic compounds showcases his commitment to advancing healthcare solutions. His contributions are paving the way for new treatments that can significantly improve the quality of life for patients with specific medical conditions.